Nathalie Andrieu-Abadie Ph.D
Course and current status
- Status/Position:……………... Research Director (DR2) Inserm
- D.O.B, P.O.B, Nationality:…. 22/04/1970, Lannemezan, French
- e-mail:………………….......... nathalie.andrieu@inserm.fr
- Office address: ………...…… Inserm U1037 (Team 4)
Cancer Research Center of Toulouse - Toulouse III University
Oncopôle de Toulouse - 2 avenue Hubert Curien - 31037 Toulouse Cedex 1
- ISI WoS ID:…………….….….N-6793-2013
- Biosketch:……….….…….…..1996: Doctoral training Duke University-Durham-NC-USA
1997: Ph.D in Human Pathophysiology Toulouse III University-France (with honors)
1998: Post-Doctoral Fellow Inserm U460-Paris-France. GERLI award
1999: Inserm Investigator French National Health and Medical Research Institute
2002: Habilitation to Supervise Research Toulouse III University-France
2007: Member of European organization on Sphingolipids
2010: Member of AERES. Member of the editorial board of American Journal of Cancer Research
2013: Nominated member of scientific committee of Faculty of Medicine of Toulouse-France. Organizer of the International congress on Cancer cell death and resistance Toulouse-France
2014: DR2, INSERM Research Director. Organizer of the International congress on Autophagy Toulouse-France
2016: Co-PI of ‘Sphingolipid Metabolism, Cell Death and Tumor Progression’ Group (Inserm U1037-Toulouse-France)
2016: PI of the European project IMMUSPHINX (Transcan-2, H2020-SC1)
Member of European Academy of Tumor Immunology
2017: Member of scientific committee of The French Society of Dermatology (SFD)
- Bibliometry indicators :….. Total publications : 78
h-index : 29
Total citations : 4582
- Patents:……………………….New method for treating melanoma PCT/EP2015/060512
Methods and pharmaceutical composition for the treatment of cancer PCT/EP2017/051844
Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer PCT/EP2017/052172
Methods for enhancing the potency of the immune checkpoint inhibitors PCT/EP2017/051812
Scientific summary
Main research interests: ceramide metabolism, immune escape, melanoma, resistance, tumor microenvironment.
